News and Trends 9 Dec 2022
The Native Antigen Company expands infectious disease portfolio
The Native Antigen Company (part of LGC Clinical Diagnostics), today announced the commercial release of its Sudan Ebolavirus Boniface 1976 Glycoprotein (SEBOV GP). The addition of this latest recombinant protein…
